Biomaterials and Regenerative Medicine in Ophthalmology
- 3rd Edition - September 1, 2026
- Latest edition
- Editors: Damien Harkin, Katelyn Swindle-Reilly, Ramesh Ayyala
- Language: English
Biomaterials and Regenerative Medicine in Ophthalmology, 3rd Edition, is thoroughly revised and expanded, including five more chapters than the previous edition.The b… Read more
Description
Description
Biomaterials and Regenerative Medicine in Ophthalmology, 3rd Edition, is thoroughly revised and expanded, including five more chapters than the previous edition.
The book is divided into five parts, with each providing significant updates on topics including interactions between biomaterials and the ocular surface, strategies for corneal tissue reconstruction, keratoprotheses, strategies for retinal tissue construction, biomaterials for ocular drug delivery, implants for treating glaucoma, implants for monitoring intraocular pressure, intraocular lenses, vitreal substitutes, retinal prostheses, and orbital implants.
Beginning with the ocular surface, the book progressively moves deeper into the eye as it explores the use of biomaterials, when either applied alone or in conjunction with living cells, as a means of restoring structure and/or function to ocular tissues. Notably, some chapters cover the essential background to understanding interactions between biomaterials and ocular cells and tissues, while others provide case studies of research translation from the laboratory bench to the clinic and subsequent commercialization.
Biomaterials and Regenerative Medicine in Ophthalmology, 3rd Edition, is therefore a valuable source of information for all postgraduate students, academics, clinicians, and industry-based researchers who are seeking a deeper understanding of the issues relating to the application of biomaterials and regenerative medicine in ophthalmology.
The book is divided into five parts, with each providing significant updates on topics including interactions between biomaterials and the ocular surface, strategies for corneal tissue reconstruction, keratoprotheses, strategies for retinal tissue construction, biomaterials for ocular drug delivery, implants for treating glaucoma, implants for monitoring intraocular pressure, intraocular lenses, vitreal substitutes, retinal prostheses, and orbital implants.
Beginning with the ocular surface, the book progressively moves deeper into the eye as it explores the use of biomaterials, when either applied alone or in conjunction with living cells, as a means of restoring structure and/or function to ocular tissues. Notably, some chapters cover the essential background to understanding interactions between biomaterials and ocular cells and tissues, while others provide case studies of research translation from the laboratory bench to the clinic and subsequent commercialization.
Biomaterials and Regenerative Medicine in Ophthalmology, 3rd Edition, is therefore a valuable source of information for all postgraduate students, academics, clinicians, and industry-based researchers who are seeking a deeper understanding of the issues relating to the application of biomaterials and regenerative medicine in ophthalmology.
Key features
Key features
- Fully revised to provide readers with the latest updates on strategies for using
biomaterials in strategies for ocular tissue reconstruction and the management of
ocular disorders. - Carefully structured to provide readers with essential foundational knowledge relating
to the potential impact of biomaterials on ocular tissue structure and function. - Includes case studies of research translation from the laboratory bench to the clinic.
Readership
Readership
Researchers, academics, and postgraduate students who are new to the fields of biomaterials, regenerative medicine, and ophthalmology, and who wish to gain a foundational understanding of key concepts and strategies
Table of contents
Table of contents
Part One: Biomaterial-Ocular Surface Interface
1. Ocular biotribology and the ocular/contact lens interface
2. The ageing tear film and ocular surface: biomaterials challenges
3. The design and development of hydrogels and silicone hydrogels for contact lens applications
4. Advances in contact lens design
Part Two: Strategies for Corneal Reconstruction
5. The strengths and limitations of primary corneal cells
6. Potential for corneal cells from iPS cells
7. Biomaterials for repairing the corneal epithelium
8. Biomaterials for stromal reconstruction
9. Kuragel - Liquid cornea
10. Biomaterials for corneal endothelial cell transplantation
Part Three: Strategies for Retinal Reconstruction
11. Biomaterials for retinal tissue engineering
12. Neural retina
13. RPE and choroid
14. Optic nerve
Part Four: Biomaterials for Ocular Drug Delivery
15. Topical delivery of ophthalmic drugs
16. Slow-release drug platforms for ophthalmology
17. Slow-release glaucoma drug delivery systems
18. Intra-vitreal drug delivery
Part Five: Other Applications
19. Hydrogels for ophthalmological use: physiochemical and structural considerations
20. Polymer science in glaucoma implants
21. Advances in intraocular lenses
22. Vitreal substitutes
23. Keratoprotheses
24. Orbital implants
25. Retinal prostheses - lessons learned
26. IOP monitoring systems
1. Ocular biotribology and the ocular/contact lens interface
2. The ageing tear film and ocular surface: biomaterials challenges
3. The design and development of hydrogels and silicone hydrogels for contact lens applications
4. Advances in contact lens design
Part Two: Strategies for Corneal Reconstruction
5. The strengths and limitations of primary corneal cells
6. Potential for corneal cells from iPS cells
7. Biomaterials for repairing the corneal epithelium
8. Biomaterials for stromal reconstruction
9. Kuragel - Liquid cornea
10. Biomaterials for corneal endothelial cell transplantation
Part Three: Strategies for Retinal Reconstruction
11. Biomaterials for retinal tissue engineering
12. Neural retina
13. RPE and choroid
14. Optic nerve
Part Four: Biomaterials for Ocular Drug Delivery
15. Topical delivery of ophthalmic drugs
16. Slow-release drug platforms for ophthalmology
17. Slow-release glaucoma drug delivery systems
18. Intra-vitreal drug delivery
Part Five: Other Applications
19. Hydrogels for ophthalmological use: physiochemical and structural considerations
20. Polymer science in glaucoma implants
21. Advances in intraocular lenses
22. Vitreal substitutes
23. Keratoprotheses
24. Orbital implants
25. Retinal prostheses - lessons learned
26. IOP monitoring systems
Product details
Product details
- Edition: 3
- Latest edition
- Published: September 1, 2026
- Language: English
About the editors
About the editors
DH
Damien Harkin
Damien G. Harkin is a Professor at the Centre for Vision and Eye Research, Queensland University of Technology, Queensland, Australia. He is an experienced teacher and medical researcher, in the areas of human structure, function and disease His main area of research focus for the last 20 years has been the development of cell and tissue therapies for the treatment of common and severe eye diseases. This research has been supported by over $3M dollars in research funding and has led to over 80 publications in peer-reviewed journals and book chapters. Professor Harkin received his BSc and PhD (Pathology) from the University of Adelaide (1993) before completing postdoctoral training at Harvard Medical School (1994-1996) and the University of Melbourne (1997). He commenced working at QUT as a lecturer in 2001 and was promoted to Professor in 2016. Professor Harkin also holds honorary positions at the Queensland Eye Institute (since 2005) and Australian Red Cross LifeBlood (since 2020).
Affiliations and expertise
Centre for Vision and Eye Research, Queensland University of Technology, Queensland, AustraliaKS
Katelyn Swindle-Reilly
Dr Katelyn Swindle-Reilly is an Associate Professor and College of Engineering Innovation Scholar, The Ohio State University, Ohio, USA. She is tenured faculty with appointments in Biomedical Engineering, Chemical and Biomolecular Engineering, and Ophthalmology and Visual Sciences at The Ohio State University. She has degrees in Chemical Engineering, with a B.S. from Georgia Institute of Technology, and M.S. and Ph.D. from Washington University in St. Louis. She has managed multiple research projects from initial research phase through manufacturing and regulatory approval, including serving as Chief Technology Officer of an ophthalmic startup company. Dr. Swindle-Reilly’s research lab focuses on the design of polymeric biomaterials for soft tissue repair and drug delivery with focused applications in ophthalmology.
Affiliations and expertise
The Ohio State University, Ohio, USARA
Ramesh Ayyala
Dr. Ramesh Ayyala, MD, FRCS, FRCOphth is a world-renowned ophthalmologist and is the Professor and Chair of Ophthalmology at the University of South Florida, Tampa, FL, USA, where he also holds the James P. and Heather Gills Chair in Ophthalmology. Prior to USF, Dr. Ayyala was a tenured professor of ophthalmology, director of the glaucoma service, and residency/fellowship director at Tulane University. He is a graduate of Gandhi Medical College, Osmania University in Hyderabad. He received his residency training in ophthalmology at Mersey Region Hospitals, United Kingdom (UK), and at USF, Tampa, FL. Dr. Ayyala completed his glaucoma fellowship at Massachusetts Eye and Ear, Harvard Medical School and his cornea/external disease fellowship at Boston University Medical Center. Dr. Ayyala is board certified on three continents (India, UK and USA), a fellow of the Royal College of Ophthalmology (Lon) and the Royal College of Surgeons (Edinburgh), and the American Academy of Ophthalmology. He is a past president of the Louisiana Academy of Eye Physicians and Surgeons.
Affiliations and expertise
University of South Florida, Tampa, Florida, USA